Global In Vivo and In Vitro ADME Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028216 No. of Pages: 109 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global In Vivo and In Vitro ADME market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the In Vivo and In Vitro ADME market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of In Vivo and In Vitro ADME in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Small Molecules
Biologics
Market Snapshot, By Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
Main Market Players Analyzed in this report, including:
WuXi AppTec
Tecan Group
Syneos Health
Shanghai Medicilon
Sai Life Sciences
RTI International
Pharmaron
Lonza
Labcorp
Joinn Laboratories
IQVIA
ICON
Evotec
Eurofins Scientific
Envigo
Curia
ChemPartner
Charles River
Bioduro-Sundia
Aragen Life Sciences
The study objectives of this report are:
To study and analyze the global In Vivo and In Vitro ADME market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of In Vivo and In Vitro ADME market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global In Vivo and In Vitro ADME manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the In Vivo and In Vitro ADME market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of In Vivo and In Vitro ADME submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of In Vivo and In Vitro ADME are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 In Vivo and In Vitro ADME Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global In Vivo and In Vitro ADME Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and In Vivo and In Vitro ADME
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Biopharmaceutical Companies
3.2.2 Major Buyers in Government and Academic Institutes
4 Market Segment: by Type
4.1 In Vivo and In Vitro ADME Type Introduction
4.1.1 Small Molecules
4.1.2 Biologics
4.2 Global In Vivo and In Vitro ADME Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 In Vivo and In Vitro ADME Type Introduction
5.1.1 Biopharmaceutical Companies
5.1.2 Government and Academic Institutes
5.1.3 Others
5.2 Global In Vivo and In Vitro ADME Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global In Vivo and In Vitro ADME Market by Region
6.2 North America In Vivo and In Vitro ADME Market 2016-2021
6.3 Europe In Vivo and In Vitro ADME Market 2016-2021
6.4 Asia Pacific In Vivo and In Vitro ADME Market 2016-2021
6.5 South America In Vivo and In Vitro ADME Market 2016-2021
6.6 Middle East and Africa In Vivo and In Vitro ADME Market 2016-2021
7 North America
7.1 North America In Vivo and In Vitro ADME Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe In Vivo and In Vitro ADME Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific In Vivo and In Vitro ADME Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America In Vivo and In Vitro ADME Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa In Vivo and In Vitro ADME Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 WuXi AppTec
12.1.1 WuXi AppTec
Company Information
12.1.2 WuXi AppTec
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.1.3 WuXi AppTec
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.1.4 WuXi AppTec
Key Development
12.2 Tecan Group
12.2.1 Tecan Group
Company Information
12.2.2 Tecan Group
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.2.3 Tecan Group
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.2.4 Tecan Group
Key Development
12.3 Syneos Health
12.3.1 Syneos Health
Company Information
12.3.2 Syneos Health
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.3.3 Syneos Health
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.3.4 Syneos Health
Key Development
12.4 Shanghai Medicilon
12.4.1 Shanghai Medicilon
Company Information
12.4.2 Shanghai Medicilon
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.4.3 Shanghai Medicilon
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.4.4 Shanghai Medicilon
Key Development
12.5 Sai Life Sciences
12.5.1 Sai Life Sciences
Company Information
12.5.2 Sai Life Sciences
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.5.3 Sai Life Sciences
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.5.4 Sai Life Sciences
Key Development
12.6 RTI International
12.6.1 RTI International
Company Information
12.6.2 RTI International
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.6.3 RTI International
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.6.4 RTI International
Key Development
12.7 Pharmaron
12.7.1 Pharmaron
Company Information
12.7.2 Pharmaron
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.7.3 Pharmaron
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.7.4 RTI International
Key Development
12.9 Labcorp
12.9.1 Labcorp
Company Information
12.9.2 Labcorp
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.9.3 Labcorp
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.9.4 Labcorp
Key Development
12.8 Lonza
12.8.1 Lonza
Company Information
12.8.2 Lonza
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.8.3 Lonza
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.8.4 Lonza
Key Development
12.11 IQVIA
12.11.1 IQVIA
Company Information
12.11.2 IQVIA
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.11.3 IQVIA
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.11.4 IQVIA
Key Development
12.12 ICON
12.12.1 ICON
Company Information
12.12.2 ICON
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.12.3 ICON
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.12.4 ICON
Key Development
12.13 Evotec
12.13.1 Evotec
Company Information
12.13.2 Evotec
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.13.3 Evotec
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.13.4 Evotec
Key Development
12.14 Eurofins Scientific
12.14.1 Eurofins Scientific
Company Information
12.14.2 Eurofins Scientific
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.14.3 Eurofins Scientific
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.14.4 Eurofins Scientific
Key Development
12.15 Envigo
12.15.1 Envigo
Company Information
12.15.2 Envigo
In Vivo and In Vitro ADME Product Portfolio, Specification and Application
12.15.3 Envigo
In Vivo and In Vitro ADME Revenue and Gross Margin (2019-2021)
12.15.4 Envigo
Key Development
12.17 ChemPartner
12.18 Charles River
12.19 Bioduro-Sundia
12.20 Aragen Life Sciences
13 Global In Vivo and In Vitro ADME Market Forecast by Region by Type and by Application
13.1 Global In Vivo and In Vitro ADME Revenue Forecast 2022-2027
13.2 Global In Vivo and In Vitro ADME Forecast by Regions
13.3 Global In Vivo and In Vitro ADME Forecast by Type
13.4 Global In Vivo and In Vitro ADME Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com